Celldex Therapeutics Inc. (CLDX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Celldex Therapeutics Inc.

    NASDAQ: CLDX · Real-Time Price · USD
    26.41
    0.56 (2.17%)
    At close: Oct 03, 2025, 3:59 PM

    Celldex Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -157.86M -141.43M -112.33M -70.51M
    Depreciation & Amortization
    		 -12.57M 3.01M 2.9M 3.07M
    Stock-Based Compensation
    		 34.24M 23.89M 15.61M 8.95M
    Other Working Capital
    		 -35.16M 6.36M -6.85M -6.28M
    Other Non-Cash Items
    		 16K -6.22M -5.79M -1.14M
    Deferred Income Tax
    		 n/a n/a -227K -227K
    Change in Working Capital
    		 -21.6M 13.46M -3.9M -1.05M
    Operating Cash Flow
    		 -157.78M -107.29M -103.73M -60.91M
    Capital Expenditures
    		 -1.92M -1.82M -1.83M -1.25M
    Cash Acquisitions
    		 n/a n/a 69K 27K
    Purchase of Investments
    		 -789.92M -424.56M -188.97M -389.88M
    Sales Maturities Of Investments
    		 501.71M 320.6M 280.67M 174.95M
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 -290.13M -105.78M 89.94M -216.16M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a n/a 2.48M
    Financial Cash Flow
    		 441.45M 218.46M 4.08M 272.37M
    Net Cash Flow
    		 -6.46M 5.38M -9.71M -4.69M
    Free Cash Flow
    		 -159.7M -109.11M -105.56M -62.16M

    Add to Watchlist